Invention Grant
- Patent Title: Methods of administering lipid formulations with immunogens
-
Application No.: US17560059Application Date: 2021-12-22
-
Publication No.: US11766401B2Publication Date: 2023-09-26
- Inventor: Andrew Geall
- Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals SA
- Current Assignee: GlaxoSmithKline Biologicals SA
- Current Assignee Address: BE Rixensart
- Agency: Knobbe Martens Olson & Bear LLP
- The original application number of the division: US13808080
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A61K9/127 ; A61K39/12 ; C12N15/86 ; A61K31/7088 ; A61K39/00 ; A61K39/39
Abstract:
RNA encoding an immunogen is delivered in a liposome for the purposes of immunisation. The liposome includes lipids which have a pKa in the range of 5.0 to 7.6 and, preferably, a tertiary amine. These liposomes can have essentially neutral surface charge at physiological pH and are effective for immunisation.
Public/Granted literature
- US20220125724A1 METHODS OF ADMINISTERING LIPID FORMULATIONS WITH IMMUNOGENS Public/Granted day:2022-04-28
Information query
